Dolasetron versus ondansetron as single-agent prophylaxis for patients at increased risk for postoperative nausea and vomiting: A prospective, double-blind, randomized trial

Military Medicine

Volumn 171, Issue 9, 2006, Pages 913-916

  Birmingham, Sean D ^a   Mecklenburg, Brian W ^a   Lujan, Eugenio ^a   Dacanay, Rhodel G ^a   Boyle, Patrick K ^a   Green, Richard ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOLASETRON MESILATE; FENTANYL; MORPHINE; ONDANSETRON; OPIATE;

ADULT; AMBULATORY SURGERY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL ANESTHESIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTION SICKNESS; PATIENT CARE; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 33748773888     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.171.9.913     Document Type: Article

References (15)

1. Gan TJ, Meyer T, Apfel CC, et al: Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62-71.
2. Carroll NV, Miederhoff P, Cox FM, Hirsch JD: Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg 1995; 80: 903-9.
3. Can TJ, Franiak R, Reeves J: Ondansetron orally disintegrating tablet versus ; placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery. Anesth Analg 2002; 94: 1199-200.
4. Macario A, Weinger M, Carney S, Kim A: Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 1999; 89: 652-8.
5. Gan TJ: Postoperative nausea and vomiting: can it be eliminated? JAMA 2002; 287: 1233-6.
6. Apfel CC, Greim A, Haubitz I, et al: A risk score to predict the probability of postoperative vomiting in adults. Acta Anesthiol Scand 1998; 42: 495-501.
7. Korttila K, Clergue F, Leeser J, et al: Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. Acta Anaesthesiol Scand 1997; 41: 914-22.
8. Apfel CC, Korttila K, Abdalla M, et al: A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350: 2441-51.
9. White PF: Prevention of postoperative nausea and vomiting: a multimodal solution to a persistent problem. N Engl J Med 2004; 350: 2511-2.
10. Zarate E, Watcha MF, White PF, Klein KW, Sa Rego M, Stewart DG: A comparison of the costs and efficacy of ondansetron versus dolasetron for antiemetic prophylaxis. Anesth Analg 2000; 90: 1352-8.
11. Browning BA, Fort CA, Kemp KD, Shimata MF, Strube MD: Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures. AANA J 2004; 72: 129-32.
12. 3 receptor antagonists: tropisetron, ondansetron and dolasetron. Anaesth Intensive Care 2003; 31: 11-7.
13. Pronovost PJ, Berenholtz SM, Dorman T, Merritt WT, Martinez EA, Guyatt GH: Evidence-based medicine in anesthesiology. Anesth Analg 2001; 92: 787-94.
14. Sener EB, Kocamanoglu S, Cetinkaya MB, Ustun E, Bildik E, Tur A: Effects of menstrual cycle on postoperative analgesic requirements, agitation, incidence of nausea and vomiting after gynecological laparoscopy. Gynecol Obstet Invest 2004; 59: 49-53.
15. Heidari SM, Saryazdi H, Saghaei M: Effect of intravenous midazolam premedication on postoperative nausea and vomiting after cholecystectomy. Acta Anaesthesiol Taiwan 2004; 42; 77-80.